26 research outputs found

    Chimeric Antigen Receptor-Redirected Regulatory T Cells Suppress Experimental Allergic Airway Inflammation, a Model of Asthma

    Get PDF
    Cellular therapy with chimeric antigen receptor (CAR)-redirected cytotoxic T cells has shown impressive efficacy in the treatment of hematologic malignancies. We explored a regulatory T cell (Treg)-based therapy in the treatment of allergic airway inflammation, a model for asthma, which is characterized by an airway hyper-reactivity (AHR) and a chronic, T helper-2 (Th2) cell-dominated immune response to allergen. To restore the immune balance in the lung, we redirected Tregs by a CAR toward lung epithelia in mice upon experimentally induced allergic asthma, closely mimicking the clinical situation. Adoptively transferred CAR Tregs accumulated in the lung and in tracheobronchial lymph nodes, reduced AHR and diminished eosinophilic airway inflammation, indicated by lower cell numbers in the bronchoalveolar lavage fluid and decreased cell infiltrates in the lung. CAR Treg cells furthermore prevented excessive pulmonary mucus production as well as increase in allergen-specific IgE and Th2 cytokine levels in exposed animals. CAR Tregs were more efficient in controlling asthma than non-modified Tregs, indicating the pivotal role of specific Treg cell activation in the affected organ. Data demonstrate that lung targeting CAR Treg cells ameliorate key features of experimental airway inflammation, paving the way for cell therapy of severe allergic asthma

    Integrating Signals from the T-Cell Receptor and the Interleukin-2 Receptor

    Get PDF
    T cells orchestrate the adaptive immune response, making them targets for immunotherapy. Although immunosuppressive therapies prevent disease progression, they also leave patients susceptible to opportunistic infections. To identify novel drug targets, we established a logical model describing T-cell receptor (TCR) signaling. However, to have a model that is able to predict new therapeutic approaches, the current drug targets must be included. Therefore, as a next step we generated the interleukin-2 receptor (IL-2R) signaling network and developed a tool to merge logical models. For IL-2R signaling, we show that STAT activation is independent of both Src- and PI3-kinases, while ERK activation depends upon both kinases and additionally requires novel PKCs. In addition, our merged model correctly predicted TCR-induced STAT activation. The combined network also allows information transfer from one receptor to add detail to another, thereby predicting that LAT mediates JNK activation in IL-2R signaling. In summary, the merged model not only enables us to unravel potential cross-talk, but it also suggests new experimental designs and provides a critical step towards designing strategies to reprogram T cells

    Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study

    Get PDF
    Background Huntington's disease is caused by a CAG repeat expansion in the huntingtin gene, HTT. Age at onset has been used as a quantitative phenotype in genetic analysis looking for Huntington's disease modifiers, but is hard to define and not always available. Therefore, we aimed to generate a novel measure of disease progression and to identify genetic markers associated with this progression measure. Methods We generated a progression score on the basis of principal component analysis of prospectively acquired longitudinal changes in motor, cognitive, and imaging measures in the 218 indivduals in the TRACK-HD cohort of Huntington's disease gene mutation carriers (data collected 2008–11). We generated a parallel progression score using data from 1773 previously genotyped participants from the European Huntington's Disease Network REGISTRY study of Huntington's disease mutation carriers (data collected 2003–13). We did a genome-wide association analyses in terms of progression for 216 TRACK-HD participants and 1773 REGISTRY participants, then a meta-analysis of these results was undertaken. Findings Longitudinal motor, cognitive, and imaging scores were correlated with each other in TRACK-HD participants, justifying use of a single, cross-domain measure of disease progression in both studies. The TRACK-HD and REGISTRY progression measures were correlated with each other (r=0·674), and with age at onset (TRACK-HD, r=0·315; REGISTRY, r=0·234). The meta-analysis of progression in TRACK-HD and REGISTRY gave a genome-wide significant signal (p=1·12 × 10−10) on chromosome 5 spanning three genes: MSH3, DHFR, and MTRNR2L2. The genes in this locus were associated with progression in TRACK-HD (MSH3 p=2·94 × 10−8 DHFR p=8·37 × 10−7 MTRNR2L2 p=2·15 × 10−9) and to a lesser extent in REGISTRY (MSH3 p=9·36 × 10−4 DHFR p=8·45 × 10−4 MTRNR2L2 p=1·20 × 10−3). The lead single nucleotide polymorphism (SNP) in TRACK-HD (rs557874766) was genome-wide significant in the meta-analysis (p=1·58 × 10−8), and encodes an aminoacid change (Pro67Ala) in MSH3. In TRACK-HD, each copy of the minor allele at this SNP was associated with a 0·4 units per year (95% CI 0·16–0·66) reduction in the rate of change of the Unified Huntington's Disease Rating Scale (UHDRS) Total Motor Score, and a reduction of 0·12 units per year (95% CI 0·06–0·18) in the rate of change of UHDRS Total Functional Capacity score. These associations remained significant after adjusting for age of onset. Interpretation The multidomain progression measure in TRACK-HD was associated with a functional variant that was genome-wide significant in our meta-analysis. The association in only 216 participants implies that the progression measure is a sensitive reflection of disease burden, that the effect size at this locus is large, or both. Knockout of Msh3 reduces somatic expansion in Huntington's disease mouse models, suggesting this mechanism as an area for future therapeutic investigation

    Die Rolle der CD4+ T-Lymphozyten bei Sepsis - Untersuchungen in einem Peritonitismodell der Maus

    No full text
    Generalisierte bakterielle Infektionen, auch Sepsis genannt, sind trotz intensivmedizinischer Behandlung mit einer sehr hohen LetalitĂ€t verbunden. Um kausale Therapiestrategien zu entwickeln, ist ein besseres VerstĂ€ndnis der zugrunde liegenden Pathomechanismen, insbesondere der Reaktionen des Immunsystems, notwendig. Da die Sepsis ein hoch komplexer Vorgang ist, an dem der gesamte Organismus beteiligt ist, sind grundlegende Untersuchungen im Tiermodell dafĂŒr unverzichtbar. Nach aktuellen Modellvorstellungen verlĂ€uft die Immunreaktion bei einer Sepsis typischerweise in zwei Phasen: Auf eine ĂŒberschießenden EntzĂŒndungsantwort folgt eine Phase der generalisierten Immunparalyse. Die Rolle des angeborenen Immunsystems bei diesen Reaktionen ist gut dokumentiert, jene des adaptiven Immunsystems in der Pathogenese der Sepsis ist dagegen wenig untersucht. Ihr wurde zwar eine wichtige Rolle in der spĂ€ten Phase zugesprochen, denn die Lymphozytenapoptose trĂ€gt zur Entstehung einer Immunparalyse bei. Da adaptive Immunreaktionen jedoch einige Zeit in Anspruch nehmen, wurde eine wichtige Rolle in der frĂŒhen Phase des hoch akuten Krankheitsbildes Sepsis fĂŒr unwahrscheinlich gehalten und deshalb bisher kaum betrachtet. Wir hatten jedoch aus Vorversuchen Hinweise auf eine sehr schnelle T-Zellbeteiligung bei der Sepsis. Deshalb lag der Schwerpunkt dieser Arbeit auf der AufklĂ€rung der Rolle von CD4+ T-Lymphozyten bei Sepsis. Diese wurde in einem etablierten Sepsismodell der Maus untersucht, der Colon ascendens Stent-Peritonitis (CASP). Das Modell wurde entwickelt, um die klinische Situation von Patienten, bei denen es aufgrund der Insuffizienz einer chirurgischen Naht im Magen-Darm-Trakt zur Entwicklung einer diffusen Peritonitis kommt, möglichst genau abzubilden. Überraschend beobachteten wir bei CASP innerhalb weniger Stunden eine starke Induktion der Expression von CTLA-4 (cytotoxic T lymphocyte associated antigen-4) auf den CD4+ T-Lymphozyten. Die Expression dieses MolekĂŒls wird nach der Aktivierung von T-Zellen induziert. Dies lĂ€sst auf eine Beteiligung der CD4+ T-Zellen in einem frĂŒhen Stadium der Erkrankung schließen. Eine Depletion der CD4+ T-Zellen im Vorfeld der CASP-Operation mit dem monoklonalen Antikörper GK1.5 fĂŒhrte zu einer effektiveren Beseitigung der Bakterien aus dem Peritoneum, zu einer geringeren systemischen Verbreitung der Erreger und zu einem deutlich verbesserten Überleben der Tiere. Damit verbunden war eine verstĂ€rkte Einwanderung von Zellen des angeborenen Immunsystems in das Peritoneum. Dies impliziert, dass bei einer systemischen Dissemination kommensaler Bakterien die CD4+ T-Zellen die lokale Reaktion des angeborenen Immunsystems inhibieren, in diesem Tiermodell mit lebensbedrohlichen Konsequenzen. Die Blockade der T-Zellrezeptorvermittelten Signalgebung durch Tacrolimus (FK506) hatte dagegen keinen Einfluss auf das Überleben der Peritonitis. Dies zeigt, dass die Effekte der CD4+ T-Zellen zumindest teilweise unabhĂ€ngig von der T-Zellrezeptorvermittelten Antigenerkennung sein mĂŒssen. Eine Blockade von des inhibititorischen T-ZelloberflĂ€chenmolekĂŒls CTLA-4 bewirkte eine starke Induktion von ICOS (inducible co-stimulator) sowie eine deutliche Inhibition der Sekretion von IL-10. Die verstĂ€rkte T-Zellaktivierung und Hyperinflammation ging einher mit einem Überlebensnachteil. Zur Untersuchung der Langzeitkonsequenzen, die eine Sepsis nach sich zieht, wurden die Tiere bis zu drei Monate nach der Operation untersucht. Die Peritonitis war mit massivem Zelltod in Thymus, Milz und mesenterialen Lymphknoten assoziiert, jedoch mit unterschiedlicher Kinetik. Die systemische Infektion fĂŒhrte innerhalb kurzer Zeit zu einem fast vollstĂ€ndigen Verlust des Thymus, doch 14 Tage nach der Operation war das Organ wieder unauffĂ€llig. In der Milz hingegen setzte die Apoptose spĂ€ter ein und war nicht so ausgeprĂ€gt, hielt aber lĂ€nger an. Eine sich anschließende Hyperplasie der Milz war drei Monate nach Induktion der Peritonitis am stĂ€rksten und ein Zeichen fĂŒr eine noch nicht abgeschlossene Immunreaktion. Neben der Aktivierung von T-Zellen in der frĂŒhen Phase der Erkrankung wurde auch etwa eine Woche nach der Operation eine Reaktion von T-Zellen anhand der Änderung von OberflĂ€chenmolekĂŒlen und der Sekretion von Zytokinen beobachtet. Diese Aktivierung erfolgte aufgrund der Kinetik vermutlich auf dem „klassischen“ Weg. Das Muster der ZytokinausschĂŒttung lĂ€sst vermuten, dass nach CASP eine Th1-Antwort ĂŒberwiegt. Ein weiteres wichtiges Ergebnis dieser Dissertation ist, dass nach diffuser Peritonitis ein ImmungedĂ€chtnis aufgebaut wird. Es entwickelten sich funktionsfĂ€hige Keimzentren, und im Serum ließen sich ungewöhnlich hohe Konzentrationen von Antikörpern der Klassen IgM und IgG messen. Die Bildung von T-GedĂ€chtniszellen ging damit einher. Erste Immunisierungsversuche mit TNP-KLH zu verschiedenen Zeitpunkten vor oder nach CASP deuten darauf hin, dass die Peritonitis weder die Entwicklung einer primĂ€ren Immunantwort verhinderte noch ein bereits etabliertes ImmungedĂ€chtnis störte. Im multifaktoriellen Prozess einer Sepsis spielen folglich auch die T-Lymphozyten eine wichtige Rolle. Dies sollte bei der Entwicklung neuer Therapiestrategien berĂŒcksichtigt werden. Dabei ist jedoch zu beachten, dass die Population der CD4+ T-Lymphozyten sehr heterogen ist und verschiedene Funktionen bei der Abwehr bakterieller Infektionen ausĂŒbt. Deshalb ist die Elimination der Gesamtheit der CD4+ T-Zellen höchstwahrscheinlich keine Behandlungsoption bei der Sepsis, obwohl sie in dieser Arbeit beim Tiermodell einen deutlichen Überlebensvorteil bewirkte. Es ist jetzt notwendig, die Funktionen der verschiedenen T-Zellsubpopulationen bei generalisierten bakteriellen Infektionen im Detail zu untersuchen. Die Herausforderung liegt in der Identifikation von wichtigen Kontrollpunkten der T-Zellen, die therapeutischen Eingriffen zugĂ€nglich sind. Bei diesen Interventionen muss die Gefahr einer starken Dysbalance des Immunsystems vermieden werden. Es ist ebenso wichtig zu beachten, dass die Reaktion des Immunsystems nicht nach der akuten Phase einer Sepsis endet, sondern Monate - möglicherweise sogar Jahre - danach andauert, wie in dieser Arbeit gezeigt wird. Dies könnte erklĂ€ren, warum sich bei Patienten, die diese Erkrankung ĂŒberlebt haben, bis zu fĂŒnf Jahren spĂ€ter eine signifikant erhöhte MortalitĂ€t epidemiologisch nachweisen lĂ€sst. Eine besseres VerstĂ€ndnis der immunologischen Langzeitkonsequenzen einer Sepsis ist die Voraussetzung fĂŒr die Entwicklung therapeutischer Strategien zur Senkung der MortalitĂ€t bei Überlebenden dieser schweren Erkrankung. In einer prospektiven klinischen Pilotstudie sollte ĂŒberprĂŒft werden, ob die aus den tierexperimentellen Versuchen gewonnenen Befunde auch fĂŒr den Menschen Relevanz haben könnten. Hierzu wurde die Expression von CTLA-4 als Parameter einer Beteiligung von T-Zellen bei Patienten untersucht, die sich einem großen abdominalchirurgischen Eingriff unterzogen, welcher mit einem hohen Risiko fĂŒr die Entwicklung einer Sepsis verbunden war. Bei allen Patienten zeigten sich eine teilweise dramatische Abnahme der CD3+ T- Zellen, bei dem ĂŒberwiegenden Teil der Patienten war ein Anstieg der Expression von CTLA-4 zu beobachten. Mit der Induktion des MolekĂŒls einhergehend waren Änderungen der klinischen Parameter, der Zusammensetzung der T-Zellpopulationen und deren Aktivierungszustand, so dass die Bestimmung der Expression von CTLA-4 fĂŒr die Beurteilung des Immunstatus der Patienten nĂŒtzlich sein könnte. Da die Messung jedoch sehr aufwĂ€ndig, zeitintensiv und schwer standardisierbar ist, erscheint sie aktuell ungeeignet fĂŒr die Routinediagnostik.Abdominal sepsis and septic shock are leading causes of death in intensive care units. The role of T cells in these generalized bacterial infections is still under debate. To address this, we have used CASP (colon ascendens stent peritonitis) as a murine model of polymicrobial sepsis: Implantation of a stent of defined diameter into the colon ascendens wall leads to the continuous efflux of gut bacteria into the peritoneal cavity and results in systemic inflammation. Contrary to textbook knowledge, we found strong upregulation of CTLA-4 (CD152) expression by CD4+ T cells already within 12 hours after CASP. CTLA-4, which shows sequence homology to CD28, is constitutively expressed on CD4+CD25+ T regulatory cells (Treg) and generally upregulated on T cells after activation. The aim of the first part of this thesis was to elucidate the role of T cells. We performed the following experiments: (1) Depletion of the CD4+ T cells with a monoclonal antibody improved local bacterial clearance from the peritoneal cavity, reduced bacterial dissemination and resulted in better survival of the septic mice. This was accompanied by substantially increased immigration of granulocytes and macrophages into the peritoneal cavity indicating that CD4+ T cells inhibit the local innate immune response. (2) Blockade of CTLA-4 with a monoclonal antibody caused an overwhelming systemic activation of T lymphocytes in conjunction with a suppression of systemic IL-10 release, which led to higher mortality within the first 72 hours. This underlines that the control of early T cell activation is crucially important in bacterial sepsis. (3) Blockade of TCR signaling by tacrolimus did not influence the survival of septic mice, showing that the effects of the CD4+ T lymphocytes were independent of TCR-mediated antigen recognition. We conclude that in diffuse peritonitis caused by commensal gut bacteria the CD4+ T lymphocytes exert a net negative effect on the local anti-bacterial defense and thereby contribute to bacterial dissemination and poor outcome. The second part of the thesis addresses the long-term consequences of sepsis. For this mice were investigated up until three months after surgery. We found that apoptosis was induced rapidly after surgery in thymus and other lymphoid organs and went on for several days. The spleen showed a massive hyperplasia three months after surgery. The T cell activation was biphasic. Following their rapid reaction within hours, which has been described, a second wave of T lymphocyte activation was observed seven days after surgery. This was accompanied by changes in the expression of cell surface markers and by the secretion of cytokines. The released cytokines indicated the dominance of a Th1 profile after CASP. We also determined the development of immunological memory after diffuse peritonitis. We observed the formation of germinal centres and measured unusual high serum concentrations of IgM and IgG. The development of the phenotype of T memory cells went along with this. In the attachment, finally, we describe the results of a prospective clinical trial, in which we measured the expression of CTLA-4 as a marker for T cell activation on peripheral blood cells of patients who underwent an abdominal surgery, associated with a high risk to develop complications such as sepsis. All patients showed a dramatic reduction in the number of CD3+ T cells and most experienced a strong increase in CTLA-4 expression, indicating that in the human T cells take part in the immune response to abdominal surgery with or without subsequent infection

    IL-10 Producing B Cells Protect against LPS-Induced Murine Preterm Birth by Promoting PD1- and ICOS-Expressing T Cells

    Get PDF
    B cells and in particular IL-10-secreting B cells emerge as important players in immune balance during pregnancy. We have recently revealed that CD19-deficient (CD19−/−), B cell-specific IL-10-deficient (BIL-10−/−) and B cell-deficient µMT pregnant mice are highly susceptible to LPS-induced preterm birth (PTB). We aimed to analyze the ability of IL-10-secreting cells to protect from PTB and the underlying mechanisms. Wild type (WT), CD19−/−, BIL-10−/− and µMT mice were treated with LPS at gd16 and the cellular immune response was investigated 24 h later. LPS-treated BIL-10−/− dams showed a more pronounced PTB phenotype compared to WT, CD19−/− and µMT females, and increased inflammatory and reduced anti-inflammatory mediator concentrations in the peritoneal cavity and serum. CD19−/−, BIL-10−/− and µMT mice displayed altered immune cell population frequencies in the blood and uterus with lower numbers of IL-10-secreting B cells and T cells. BIL-10−/− mothers presented decreased frequencies of uterine CD4+CD25+Foxp3+ Treg cells. Co-stimulatory molecules are critical for feto-maternal tolerance and IL-10 secretion. We found dysregulated PD-1 expression in peripheral blood and ICOS expression in the uterus of CD19−/−, BIL-10−/− and µMT dams. Our data show that B cell-specific IL-10-signaling is essential for a balanced maternal immune response to an inflammatory stimulant that cannot be hampered without IL-10-secreting B cells

    Dementia-associated changes of immune cell composition within the cerebrospinal fluid

    No full text
    Inflammation and alterations in essential protein structures in the brain might also change the cellular distribution in the cerebrospinal fluid (CSF).Using flow cytometry, we analyzed cell populations of the innate and adaptive immune system associated with the most frequent forms of dementias. We included patients with mild cognitive impairment (MCI; N ​= ​33), Alzheimer’s disease (AD; N ​= ​90), vascular dementia (VD; N ​= ​35) and frontotemporal dementia (FTD; N ​= ​17) at the time of diagnosis, before onset of treatment and 11 elderly non-demented individuals. Dependent on the form of dementia, an increased frequency of CD14+ monocytes, NK cells and NKT cells was measured. Within the T cell population, a dementia-associated shift from central memory towards (late-stage) effector cells was detected. T cells and NKT cells were correlated with MMSE, NK and NKT cells were correlated with ptau, CD14+ monocytes and NK cells were correlated with Amyloid-ÎČ 1–40.Our data suggest that each investigated immune cell type is involved in dementia-associated alterations within the CSF, possibly having distinct functions in their pathogenesis

    Altered expression of costimulatory molecules in dementias

    No full text
    Although the expression of co-stimulatory molecules plays an important role in the immune system, only little is known about their regulation in dementias. Therefore, we determined the expression of CD28, ICOS (CD278) and CTLA-4 (CD152) by CD4 + and CD8 + T cells in the peripheral blood of patients with mild cognitive impairment (MCI; N = 19), Alzheimer's disease (AD; N = 51), vascular dementia (VD; N = 21) and frontotemporal dementia (FTD; N = 6) at the point in time of diagnosis compared to 19 non-demented elderly persons. The expression of CD28 and ICOS by CD4 + and CD8 + T cells was not changed in AD, FTD or VD patients. The expression of the negative regulator CTLA-4 was increased by CD4 + T cells from AD and FTD patients and by CD8 + T cells from VD patients. The classification of the AD patients according to the severity of the disorder showed stage-dependent alterations of CD28, ICOS and CTLA-4 expression. In AD patients, the correlation analysis showed an association between the decline in CD28 + T cells and the increase in CTLA-4 + T cells with cognitive decline, measured by the mini-mental state examination (MMSE), tau proteins and Amyloid-ÎČ, important AD biomarkers in cerebrospinal fluid (CSF). In FTD patients, a positive association between Q Albumin, a marker for blood-CSF-barrier function, and CD28 and a negative correlation between Q Albumin and ICOS expression were determined. Our data suggest a dysregulated balance between the expression of negative and positive co-stimulatory molecules by T cells in AD patients, which might contribute to chronic inflammation observed in dementia

    VGF Expression by Monocytes in Patients with Alzheimer’s Disease and Vascular Dementia

    No full text
    Because its secretion is changed in cerebrospinal fluid and peripheral blood, the neuronal polypeptide VGF (nonacronymic) has been discussed as a biomarker for neuropsychiatric disorders. We have shown an enhanced VGF expression by T-cells from Alzheimer's disease (AD) patients. In this study, we investigated the VGF expression by peripheral monocytes in 38 AD patients, 5 patients with vascular dementia (VD), and 20 neuropsychiatrically healthy individuals using flow cytometry. We determined an enhanced number of VGF-expressing monocytes in VD patients compared to AD patients. VGF+CD14+ monocytes were not correlated with age, body mass index, Mini-Mental State Examination (MMSE), or Q albumin. These preliminary data support findings indicating that VGF might play a role as a peripheral biomarker in VD

    Immunomodulation by memantine in therapy of Alzheimer's disease is mediated through inhibition of Kv1.3 channels and T cell responsiveness.

    Get PDF
    Memantine is approved for the treatment of advanced AlzheimerÂŽs disease (AD) and reduces glutamate-mediated neuronal excitotoxicity by antagonism of N-methyl-D-aspartate receptors. In the pathophysiology of AD immune responses deviate and infectious side effects are observed during memantine therapy. However, the particular effects of memantine on human T lymphocytes are unresolved. Here, we provide evidence that memantine blocks Kv1.3 potassium channels, inhibits CD3-antibody- and alloantigen-induced proliferation and suppresses chemokine-induced migration of peripheral blood T cells of healthy donors. Concurrent with the in vitro data, CD4+ T cells from AD patients receiving therapeutic doses of memantine show a transient decline of Kv1.3 channel activity and a long-lasting reduced proliferative response to alloantigens in mixed lymphocyte reactions. Furthermore, memantine treatment provokes a profound depletion of peripheral blood memory CD45RO+ CD4+ T cells. Thus, standard doses of memantine profoundly reduce T cell responses in treated patients through blockade of Kv1.3 channels. This may normalize deviant immunopathology in AD and contribute to the beneficial effects of memantine, but may also account for the enhanced infection rate
    corecore